Hims & Hers Q2 revenue beat offset by wider-than-expected loss

Hims & Hers Q2 revenue beat offset by wider-than-expected loss

Tue, August 11, 2026 at 6:35 PM GMT+3 2 min read

• HIMS -3.19%

Hims & Hers Health (NYSE:HIMS) delivered mixed second-quarter results, with revenue beating Wall Street expectations while its quarterly loss came in wider than analysts had forecast as the company incurred restructuring charges tied to its shift toward branded GLP-1 weight-loss options.

Revenue for the quarter ended June 30 rose 38% year over year to $753.2 million, topping the roughly $699 million analysts had expected. The company reported a loss of $0.37 per share, compared with expectations for a loss of about $0.05 per share.

Total subscribers increased 19% year over year to nearly 2.9 million.

"Our second quarter results were defined by a significant re-acceleration in our growth profile and the continued expanding reach of our platform," Hims & Hers CFO Yemi Okupe said in a statement..

"Domestic revenue growth accelerated to 16% year-over-year, and our international business grew more than 17-fold, strengthened by the close of our Eucalyptus acquisition in June."

The company raised its full-year 2026 revenue outlook to between $3.1 billion and $3.3 billion, from its previous guidance, and forecast adjusted EBITDA of $275 million to $325 million, representing an adjusted EBITDA margin of 9% to 10%.

For the third quarter, Hims & Hers expects revenue of $880 million to $900 million and adjusted EBITDA of $75 million to $95 million, implying an adjusted EBITDA margin of 9% to 11%.

Hims & Hers CEO Andrew Dudum said the company was focused on expanding its health platform and developing what it described as a doctor-led AI clinical engine.

"We have never been better positioned to move faster or go further than we are today," Dudum said. "As we rebuild the consumer health experience from the ground up with a doctor-led AI clinical engine, the depth and breadth of our relationships with customers worldwide has never been greater."

Shares of Hims & Hers were down about 1% following the results.